STOCKHOLM — New data on a needle-free nasal delivery system for glucagon for use in severe hypoglycemia presented at the European Association for the Study of Diabetes (EASD) 2015 Meeting here today ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...

Please provide your email address to receive an email when new articles are posted on . Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type ...

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA ...

(HealthDay News) — For patients with type 1 diabetes, intranasal glucagon is effective for treating insulin-induced hypoglycemia, according to a study published online in Diabetes Care. Michael R.

New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...

Fresenius Kabi announced the launch of Glucagon Emergency Kit for the treatment of severe hypoglycemic episodes in adult and pediatric patients with diabetes. Fresenius Kabi announced the launch of ...

Hypoglycemia (low blood sugar) treatments will depend on the severity of symptoms and how low the blood sugar level has fallen. Mild hypoglycemia symptoms can be treated with high-sugar foods or ...

Xeris Pharmaceuticals Inc XERS shares are advancing on above-average volume Tuesday following a positive data readout from the company. Xeris said an in-clinic Phase 2 study that evaluated its ...

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood ...